Literature DB >> 8636009

Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: vascular endothelial growth factor/basic fibroblast growth factor and interleukin-8.

Y Wakabayashi1, T Shono, M Isono, S Hori, K Matsushima, M Ono, M Kuwano.   

Abstract

In this study, we examined whether human glioma cells are angiogenic in a model using human microvascular endothelial cells, and also which factor is responsible for the glioma-dependent angiogenesis. Tubular morphogenesis in type I collagen gel by human microvascular endothelial cells was stimulated in the presence of 10 and 100 ng/ml of vascular endothelial growth factor (VEGF), 10 ng/ml basic fibroblast growth factor (bFGF) and 10 ng/ml of interleukin-8 (IL-8). Tube formation of the microvascular endothelial cells was assayed in the glioma cell lines IN157 and IN301, co-cultured using the double chamber method. IN301 cells had much higher levels of VEGF, bFGF and transforming growth factor-beta mRNA than IN157 cells, whereas the two had similar levels of transforming growth factor-alpha mRNA. By contrast, IN157 cells had much higher levels of IL-8 mRNA than IN301 cells. IN301-dependent tubular morphogenesis was inhibited by anti-VEGF or anti-bFGF antibody, and the inhibition was almost complete when anti-VEGF and anti-bFGF antibodies were present. On the other hand, IN157-dependent tubular morphogenesis was inhibited by anti-IL-8 antibody, but not by anti-VEGF or anti-bFGF antibodies. These findings demonstrated dual paracrine controls of tumor angiogenesis by human glioma cells. One is mediated through VEGF and/or bFGF, and the other, through IL-8.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8636009      PMCID: PMC5920670          DOI: 10.1111/j.1349-7006.1995.tb03314.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  40 in total

1.  Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor.

Authors:  R R Lobb; E M Alderman; J W Fett
Journal:  Biochemistry       Date:  1985-09-10       Impact factor: 3.162

2.  Basic fibroblast growth factor induces angiogenesis in vitro.

Authors:  R Montesano; J D Vassalli; A Baird; R Guillemin; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  A sensitive enzyme-linked immunosorbent assay for human interleukin-8.

Authors:  Y Ko; N Mukaida; A Panyutich; N N Voitenok; K Matsushima; T Kawai; T Kasahara
Journal:  J Immunol Methods       Date:  1992-05-18       Impact factor: 2.303

4.  Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.

Authors:  D Zagzag; D C Miller; Y Sato; D B Rifkin; D E Burstein
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

5.  Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.

Authors:  T Abe; T Mori; K Kohno; M Seiki; T Hayakawa; H G Welgus; S Hori; M Kuwano
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

6.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  SPARC is a source of copper-binding peptides that stimulate angiogenesis.

Authors:  T F Lane; M L Iruela-Arispe; R S Johnson; E H Sage
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

Review 9.  Recent developments in the cell biology of basic fibroblast growth factor.

Authors:  D B Rifkin; D Moscatelli
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

10.  Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells.

Authors:  S Ushiro; M Ono; H Izumi; K Kohno; N Taniguchi; S Higashiyama; M Kuwano
Journal:  Jpn J Cancer Res       Date:  1996-01
View more
  7 in total

1.  The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma.

Authors:  H Haghnegahdar; J Du; D Wang; R M Strieter; M D Burdick; L B Nanney; N Cardwell; J Luan; R Shattuck-Brandt; A Richmond
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

2.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis.

Authors:  S Yoshida; M Ono; T Shono; H Izumi; T Ishibashi; H Suzuki; M Kuwano
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 3.  Mechanisms of angiogenesis in gliomas.

Authors:  O Kargiotis; J S Rao; A P Kyritsis
Journal:  J Neurooncol       Date:  2006-03-23       Impact factor: 4.130

4.  Induced interleukin-8 expression in gliomas by tumor-associated macrophages.

Authors:  Tse-Ming Hong; Lee-Jene Teng; Chia-Tung Shun; Mei-Chen Peng; Jui-Chang Tsai
Journal:  J Neurooncol       Date:  2009-01-21       Impact factor: 4.130

5.  Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis.

Authors:  I Desbaillets; A C Diserens; N Tribolet; M F Hamou; E G Van Meir
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

6.  Modulation of motility and proliferation of glioma cells by hepatocyte growth factor.

Authors:  S Yamamoto; H Wakimoto; M Aoyagi; K Hirakawa; H Hamada
Journal:  Jpn J Cancer Res       Date:  1997-06

7.  The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.

Authors:  Yi-fang Ping; Xiao-hong Yao; Jian-hong Chen; Hong Liu; Dai-lun Chen; Xiang-dong Zhou; Ji Ming Wang; Xiu-wu Bian
Journal:  J Neurooncol       Date:  2007-04-06       Impact factor: 4.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.